Regulation
Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.
This marks the fourth clearance for Volpara’s breast health platform since its original authorization back in 2010.
The system is designated to be used by clinicians to monitor patients at home or in the healthcare setting.
Luxsonic's virtual reality suite, the SieVRt, landed clearance from Health Canada in order to be used in diagnostic radiology.
The move follows recent White House criticism of social media sites for spreading public health misinformation.
Clinical communication tool used in the NHS saved patient photos on smartphones.
The company says it can do all of this without harmfully interfering with other devices.
Masimo is seeking to take Apple's blood oxygenation tech off the U.S. market.
The test measures for PdG in urine to confirm that successful ovulation took place.
The company also announced a commercialization deal with Novo Nordisk.